Rezultati pretraživanja
  1. prije 18 sati

    Risk factors of intravesical recurrence in patients with after radical nephroureterectomy. from of Rinaldetti et al. article in Clinical Genitourinary Cancer >

    2 proslijeđena tweeta 2 korisnika označavaju da im se sviđa
  2. 2. velj

    Patients w/ cT3 and/or pT3N0M0 harbor worse 3-5yr CSS & Bladder Rec Free Survival when RNU is performed laparoscopically compared to Open Read more 👇

    13 proslijeđenih tweetova 25 korisnika označava da im se sviđa
  3. 31. sij

    169th event supported by With docs from 🇩🇿 & Emirates/ difficult successfully carried out thanks to BY ! then a conservative treatment of 2 cm of upper ureter in 86yrs old man with laser BY

    1 reply 9 proslijeđenih tweetova 48 korisnika označava da im se sviđa
  4. 30. sij

    Lynch Syndrome in Japanese patients with upper tract urinary carcinoma . from of Ito et al. article in . on UroToday >

    1 proslijeđeni tweet 2 korisnika označavaju da im se sviđa
  5. 6. pro 2019.

    Outstanding talk on TCGA landscape showing up to 74% FGFR3 mutations in . “Opportunity for trial” randomized study of infigratinib as adjuvant rx in pts with invasive UTUC harboring FGFR3 alterations starting soon! Help us recruit

    5 replies 14 proslijeđenih tweetova 64 korisnika označavaju da im se sviđa
  6. 29. stu 2019.

    And now performing conservative ureteroscopic treatment of 3 cm ... nice step by step demo! .. his passion for this disease is contagious!

    12 proslijeđenih tweetova 69 korisnika označava da im se sviđa
  7. 7. stu 2019.

    Great plenary session by Prof Steven Chang from at 1 “updates on upper tract urothelial carcinoma management” – mjesto: Regnum Carya Golf Resort Convention Center

    6 proslijeđenih tweetova 24 korisnika označavaju da im se sviđa
  8. 30. lis 2019.

    Flexible ureteroscope is mandatory for the UTUC conservative treatment! Great talk about & NBI by ! Urologists’ mentality should change about the UTUC management.

    1 reply 11 proslijeđenih tweetova 53 korisnika označavaju da im se sviđa
  9. 16. lis 2019.

    Offer a post-operative bladder instillation of chemotherapy after radical nephroureterectomy to lower the intravesical recurrence rate.

    1 reply 22 proslijeđena tweeta 27 korisnika označava da im se sviđa
  10. 5. ruj 2019.

    New preop nomogram predicting recurrence after NU for HIGH-grade . Free pdf available till 10/25/19. | Use complementary w/ high-risk prediction nomogram by Petros FG et al |

    1 reply 13 proslijeđenih tweetova 28 korisnika označava da im se sviđa
  11. 16. srp 2019.

    Fantastic piece that mentions in the first paragraphs . In addition to cholangio can’t wait to see trials in w @Uro_Onc et al! Story also highlights star scientist developing w !

    For tens of thousands of patients, is rewriting their stories. By targeting unique tumors, precision medicine is crushing once-untreatable cancers. But only a fraction of patients currently benefit. Can medicine close the gap?
    Prikaži ovu nit
    7 proslijeđenih tweetova 21 korisnik označava da mu se sviđa
  12. 2. lip 2019.

    Excellent work by Avery Braun of / on this News piece re cuff at NephU Critical Questions in this Space: - Does value prop for robotics exist? - Is MIS as safe as open for bulky distal HG tumors? (Pg 7)

    12 proslijeđenih tweetova 32 korisnika označavaju da im se sviđa
  13. 29. tra 2019.

    Vuelve . El próximo 8 de mayo a las 20:30 no te pierdas esta edición en la que se hablará sobre el tratamiento de tumores del tracto urinario superior con el equipo de

    1 reply 22 proslijeđena tweeta 30 korisnika označava da im se sviđa
    Prikaži ovu nit
    Prikaži ovu nit
  14. 23. tra 2019.

    Calling all patients affected by or ! Bladder cancer awareness month is just around the corner: please take a few minutes & tell us which unanswered questions would have helped you w/ your diagnosis & treatment decisions!

    32 proslijeđena tweeta 26 korisnika označava da im se sviđa
  15. 17. ožu 2019.

    Results of SAUL, atezolizumab for advanced urinary tract carcinoma

    13 proslijeđenih tweetova 33 korisnika označavaju da im se sviđa
  16. 24. svi 2018.

    Many promisses aplications of on nerve sparing during specimen examination very nice presentation by and new aplications coming soon ! (Consueling by anatomopatologist and teamwork of course)

    1 reply 10 proslijeđenih tweetova 18 korisnika označava da im se sviđa
  17. 21. svi 2018.

    Impressive early CR results for patients with ; important question would be if AEs preclude re-treatment?

    Dr. Seth Lerner presents interim analysis results of for low grade, low volume | First 34 patients with CR of ~58.8%, way surpasses FDA threshold, stricture AEs noted, durability TBD.
    10 proslijeđenih tweetova 28 korisnika označava da im se sviđa
  18. 19. ožu 2018.

    A. Birtle great presentation about POUT trial in chemotherapy vs surveillance

    19 proslijeđenih tweetova 18 korisnika označava da im se sviđa
  19. 8. stu 2017.

    Diagnostic URS for according by the great .

    Diagnostic urs 4 : when and how according to Guidelines by
    1 reply 11 proslijeđenih tweetova 25 korisnika označava da im se sviđa
  20. 8. stu 2017.

    Very convincing video on Thullium laser treatment of#UTUC by ! It is the way to go 4 conservative treatment!

    9 proslijeđenih tweetova 31 korisnik označava da mu se sviđa

Nema rezultata.

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.